These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 28775063)

  • 21. Treatment of hyponatremia induced by the syndrome of Inappropriate antidiuretic hormone secretion: a multidisciplinary spanish algorithm.
    Runkle I; Villabona C; Navarro A; Pose A; Formiga F; Tejedor A; Poch E
    Nefrologia; 2014; 34(4):439-50. PubMed ID: 25036057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of Hyponatremia in Patients with Acute Neurological Injury.
    Human T; Cook AM; Anger B; Bledsoe K; Castle A; Deen D; Gibbs H; Lesch C; Liang N; McAllen K; Morrison C; Parker D; Rowe AS; Rhoney D; Sangha K; Santayana E; Taylor S; Tesoro E; Brophy G
    Neurocrit Care; 2017 Oct; 27(2):242-248. PubMed ID: 28054290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of 3% saline vs. conivaptan in achieving hyponatremia treatment goals.
    Dominguez M; Perez JA; Patel CB
    Methodist Debakey Cardiovasc J; 2013; 9(1):49-53. PubMed ID: 23519387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia.
    Zeltser D; Rosansky S; van Rensburg H; Verbalis JG; Smith N;
    Am J Nephrol; 2007; 27(5):447-57. PubMed ID: 17664863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of oral conivaptan, a vasopressin-receptor antagonist, evaluated in a randomized, controlled trial in patients with euvolemic or hypervolemic hyponatremia.
    Annane D; Decaux G; Smith N;
    Am J Med Sci; 2009 Jan; 337(1):28-36. PubMed ID: 19057376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tolvaptan Treatment in Children with Chronic Hyponatremia due to Inappropriate Antidiuretic Hormone Secretion: A Report of Three Cases.
    Tuli G; Tessaris D; Einaudi S; De Sanctis L; Matarazzo P
    J Clin Res Pediatr Endocrinol; 2017 Sep; 9(3):288-292. PubMed ID: 28515029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recovery from hyponatremia in acute phase is associated with better in-hospital mortality rate in acute heart failure syndrome.
    Yoshioka K; Matsue Y; Kagiyama N; Yoshida K; Kume T; Okura H; Suzuki M; Matsumura A; Yoshida K; Hashimoto Y
    J Cardiol; 2016 May; 67(5):406-11. PubMed ID: 26970933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurological manifestations and morbidity of hyponatremia: correlation with brain water and electrolytes.
    Arieff AI; Llach F; Massry SG
    Medicine (Baltimore); 1976 Mar; 55(2):121-9. PubMed ID: 1256311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tolvaptan and Neurocognitive Function in Mild to Moderate Chronic Hyponatremia: A Randomized Trial (INSIGHT).
    Verbalis JG; Ellison H; Hobart M; Krasa H; Ouyang J; Czerwiec FS;
    Am J Kidney Dis; 2016 Jun; 67(6):893-901. PubMed ID: 26874645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized, double blinded, placebo-controlled trial to evaluate the efficacy and safety of tolvaptan in Chinese patients with hyponatremia caused by SIADH.
    Chen S; Zhao JJ; Tong NW; Guo XH; Qiu MC; Yang GY; Liu ZM; Ma JH; Zhang ZW; Gu F
    J Clin Pharmacol; 2014 Dec; 54(12):1362-7. PubMed ID: 24906029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [From hyponatremia to tolvaptan].
    Cernaro V; Santoro D; Lacquaniti A; Montalto G; Buemi M
    G Ital Nefrol; 2014; 31(1):. PubMed ID: 24671837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hyponatremia in older persons (II)-A clear treatment : How to detect tricks and avoid pitfalls].
    Hofmann W; Flägel K; Gosch M
    Z Gerontol Geriatr; 2020 Aug; 53(5):463-472. PubMed ID: 32691149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of serum sodium concentration and tolvaptan treatment on length of hospitalization in patients with heart failure.
    Cyr PL; Slawsky KA; Olchanski N; Krasa HB; Goss TF; Zimmer C; Hauptman PJ
    Am J Health Syst Pharm; 2011 Feb; 68(4):328-33. PubMed ID: 21289328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Electrolyte abnormalities and metabolic acidosis in two Duchenne muscular dystrophy patients with advanced congestive heart failure].
    Matsumura T; Saito T; Miyai I; Nozaki S; Kang J
    Rinsho Shinkeigaku; 2000 May; 40(5):439-45. PubMed ID: 11002725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyponatremia in heart failure.
    Farmakis D; Filippatos G; Parissis J; Kremastinos DT; Gheorghiade M
    Heart Fail Rev; 2009 Jun; 14(2):59-63. PubMed ID: 18758941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utilization and budget impact of tolvaptan in the inpatient setting among patients with heart failure and hyponatremia.
    Amin AN; Ortendahl JD; Harmon AL; Kamat SA; Stellhorn RA; Chase SL; Sundar SV
    Curr Med Res Opin; 2018 Mar; 34(3):559-566. PubMed ID: 29297709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of hyponatremia in heart failure: role of tolvaptan.
    Albert NM; Chase S
    J Cardiovasc Nurs; 2013; 28(2):176-86. PubMed ID: 22635058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of tolvaptan for euvolemic or hypervolemic hyponatremia.
    Lee MY; Kang HJ; Park SY; Kim HL; Han E; Lee EK
    Clin Ther; 2014 Sep; 36(9):1183-94. PubMed ID: 25151571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between the Serum Sodium Levels and the Response to Tolvaptan in Liver Cirrhosis Patients with Ascites and Hyponatremia.
    Hayashi M; Abe K; Fujita M; Okai K; Takahashi A; Ohira H
    Intern Med; 2018 Sep; 57(17):2451-2458. PubMed ID: 29607963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Outcome of Cirrhotic Patients with Ascites Is Improved by the Normalization of the Serum Sodium Level by Tolvaptan.
    Kogiso T; Kobayashi M; Yamamoto K; Ikarashi Y; Kodama K; Taniai M; Torii N; Hashimoto E; Tokushige K
    Intern Med; 2017 Nov; 56(22):2993-3001. PubMed ID: 28943585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.